欧盟有关知识产权的强硬规定被视为对贫困国家医药获得的威胁 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment 布鲁塞尔 – 全球公共卫生活跃分子声称，欧盟执意要在一系列自由贸易协议中添加有关医药专利的强硬规定将会妨害发展中国家获得医药。
لأحكام التجارية القوية للاتحاد الأوروبي حول الملكية الفكرية تعتبر تهديدا على نفاذ البلدان الفقيرة إلى الأدوية 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment ابروكسل- إن الجهود التي يبذلها الاتحاد الأوروبي لإدراج أحكام حول براءات المستحضرات الصيدلانية في سلسلة من اتفاقات التجارة الحرة التي يتفاوض حولها قد تشكل تهديدا على إمكانية الحصول على الأدوية في البلدان النامية، على حد قول الناشطين في مجال الصحة العامة على الصعيد العالمي.
Des dispositions renforçant la propriété intellectuelle dans certains accords de l’UE menacent l’accès aux médicaments dans les pays pauvres 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment BRUXELLES – Selon certains activistes de la santé publique mondiale, les efforts de l’Union européenne (UE) pour intégrer des dispositions sur les brevets pharmaceutiques dans un certain nombre d’accords de libre échange en cours de négociation pourraient mettre en péril l’accès aux médicaments dans les pays en développement.
Las estrictas disposiciones comerciales de la UE sobre PI representan una amenaza para el acceso de los países pobres a los medicamentos 24/02/2009 by David Cronin for Intellectual Property Watch 1 Comment BRUSELAS- Los esfuerzos de la Unión Europea para introducir disposiciones firmes en materia de patentes farmacéuticas en una serie de acuerdos de libre comercio que está negociando podrían poner en peligro el acceso a los medicamentos en los países en desarrollo, según han afirmado activistas de la salud pública a nivel mundial.
International Health Groups Warn WHO, WTO On Medicines Seizures 21/02/2009 by William New, Intellectual Property Watch 7 Comments Leading international public health advocates have sent letters to the heads of the World Health Organization and World Trade Organization calling on them to act to prevent possible circumvention of international trade rules for intellectual property rights relating to shipments of legal generic drugs bound for developing countries.
Strong EU Trade Provisions On IP Seen As Threat To Poor Nations’ Medicines Access 18/02/2009 by David Cronin for Intellectual Property Watch 2 Comments BRUSSELS – Efforts by the European Union to insert strong provisions on pharmaceutical patents in a series of free trade agreements it is negotiating could imperil access to medicines in developing countries, global public health activists have alleged. As part of trade talks being conducted with India, Colombia, Peru and a regional grouping in south-east Asia, EU officials have proposed that drug-makers should benefit from a robust intellectual property regime. National regulatory authorities in the countries concerned would be prevented for lengthy periods from using data provided by a company that holds a drug patent in order to authorise a generic version of that medicine.
US Congress, Lobbyists Renew Patent Reform Slog With Focus On Damages 17/02/2009 by Liza Porteus Viana, Intellectual Property Watch 2 Comments With patent reform expected to be introduced sooner rather than later in this 111th United States Congress, calculating damages for infringement remains one of the main sticking points.
Proponents Explore Designs For Prizes To Aid Neglected Disease Research 12/02/2009 by Kaitlin Mara for Intellectual Property Watch 2 Comments The World Health Organization global strategy on public health, innovation and intellectual property calls for the exploration of alternative mechanisms to incentivise research and development, including the use of prize funds. A diverse group of non-governmental agencies, government and pharmaceutical industry representatives recently looked at prize funds in detail, to determine different possible approaches and where they might best be applied to medical innovations.
Estalla la preocupación por el sistema de la OMC y el transporte de medicamentos; se reaviva el debate sobre los ADPIC 10/02/2009 by William New, Intellectual Property Watch Leave a Comment Los Embajadores de Brasil e India ante la Organización Mundial del Comercio (OMC) han acusado a otros miembros de la OMC de no tener fundamentos para bloquear el transporte legal de medicamentos genéricos sobre la base de posibles conflictos de derechos de propiedad intelectual (DPI) en el país de tránsito, y advirtieron que los ejemplos […]
Des inquiétudes surgissent concernant le système de l’OMC et l’acheminement de médicaments ; reprise des discussions relatives à l’Accord sur les ADPIC 09/02/2009 by William New, Intellectual Property Watch Leave a Comment Les ambassadeurs du Brésil et de l’Inde auprès de l’Organisation mondiale du commerce (OMC) ont rappelé que l’acheminement de médicaments génériques ne pouvait être bloqué par les autorités douanière du pays de transit en raison d’une atteinte potentielle aux droits de propriété intellectuelle. En agissant ainsi les autorités néerlandaises avaient, selon eux, remis en cause […]